4 Hot Analyst Reads For Friday, July 13th

Biotech Maven

Jul 13, 2018

After Cantor Fitzgerald and Canaccord Genuity gave Zynerba Pharmaceuticals (NASDAQ: ZYNE) a Buy rating last month, the company received another

Comments

Hot Analyst Reads

FEATURED

COMMUNITY

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 25, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 24, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 23, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 20, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 19, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 18, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 17, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 17, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 10, 2018

A synopsis of recent analyst activity that could buoy these small cap biotech stocks in trading today

Biotech Maven

Jul 9, 2018